ODDB.org: Open Drug Database

Sandoz Pharmaceuticals AG - Dabigatran Sandoz 150 mg, Hartkapseln

Swissmedic Registration	68658	Sequence	02
Product name	Dabigatran Sandoz 150 mg	Description	Hartkapseln
ATC-Classification	B01AE07	ATC-Description	Dabigatran Etexilate
Introduction of Sequence	07.06.2023

Composition

dabigatranum etexilatum 150 mg ut dabigatrani etexilati mesilas, acidum tartaricum, hypromellosum, talcum, hydroxypropylcellulosum, carmellosum natricum conexum, magnesii stearas, Kapselhülle: hypromellosum, E 171, Drucktinte: lacca, propylenglycolum, E 172 (nigrum), kalii hydroxidum, pro capsula corresp. natrium 0.9 mg.

Packungsbestandteile

Galenic Form

Capsules

Excipiens

Active Agent	Dose
Dabigatranum Etexilatum	150 mg

BAG: Active Agent	Dose
Dabigatranum Etexilatum	150 mg

Inactive agents		additional_information
(Nigrum)
Tartaric Acid
Carmellosum Natricum Conexum
E 171		color.
E 172		color.
Hydroxypropylcellulosum
Hypromellosum		Kapselhülle
Kalii Hydroxidum
Lacca		Drucktinte
Magnesii Stearas
Propylenglycol
Talcum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
003	60	40.97	60.95	B	SL	No
004	180	122.90	150.10	B	SL	No

2025	©ywesee GmbH